d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Byetta Cases

Share Article

The Law Firm of d'Oliveira & Associates Offers "No Win No Fee Promise" For clients injured from the insulin injection Byetta, used to treat Type 2 Diabetes. Byetta has been linked to serious side effects, such as pancreatic cancer, thyroid cancer, liver cancer, and pancreatitis.

In 2008, the U.S. Food and Drug Administration (FDA) received more than 30 reports of acute pancreatic in Byetta users. Other reports included two deaths and four hospitalizations due to pancreatic problems. Patients on Byetta should keep track of potential symptoms of chronic pancreatitis, which could lead to pancreatic cancer. The symptoms include:

  •     Abdominal pain
  •     Vomiting
  •     Fever
  •     Nausea
  •     Rapid heartbeat
  •     Swollen, tender abdomen
  •     Changes in bowel movements

Source: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm079781.htm

USA Today Reports the drug manufacturers tried to downplay the potential of Byetta to cause pancreatic cancer, thyroid cancer, and liver cancer. However, following the FDA reports, much of the upper management from the company agreed that cancer could not be ruled out as a side effect.


FDA has asked Amlin Pharmaceuticals, the manufacturer of Byetta, to include information about acute pancreatitis in the Precautions section of the drug’s label. FDA has also warned that Healthcare providers should be alert about the signs and symptoms of acute pancreatitis. The symptoms include persistent severe abdominal pain that can radiate to the back and may be accompanied by nausea and vomiting. Acute pancreatitis is typically confirmed by the presence of elevated levels of serum amylase and/or lipase and characteristic findings by radiological imaging.

FDA warns that patients should discontinue the injection of Byetta if pancreatitis is suspected. If pancreatitis is confirmed, do not restart Byetta unless an alternative etiology for the pancreatitis is identified. They have also required Amlin Pharmaceuticals to conduct six post-marketing studies to help further define the mechanism, incidence, and risk factors for the development of acute pancreatitis associated with Byetta, as well as explore a potential signal of a serious risk of thyroid cancer and pancreatic cancer.

Source: http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm079781.htm

Many patients are already aware of the dangerous side effects of Byetta. There have been a number of lawsuits filed this year. The first Byetta side effects lawsuit was filed in 2008 in San Diego Superior Court (Case No. 37-2008-00090003-CU-PL-CTL) on behalf of a Virginia man who claims that Byetta’s manufacturer and co-maker Eli Lilly & Co. failed to adequately test and monitor the side effects of Byetta. A number of attorneys also say that Amylin Pharmaceuticals and Eli Lilly & Co. have failed to adequately warn about the risks of serious and potentially fatal side effects such as pancreatic cancer, thyroid cancer, and pancreatitis. Byetta lawyers expect the number of lawsuits to skyrocket as awareness about the link between Byetta and serious side effects continues to rise.

Attorney Paul d’Oliveira stated that “It is unfortunate that the manufacturer did not properly test this drug before mass marketing it to consumers. We are working with a New York Pharmaceutial Law firm who is handling these cases nationally. We both feel persons injured from this drug will be able to collect for their damages and are very optimistic about the case.”

d’Oliveira & Associates is a law firm that is working with some of the leading attorneys in the United States for dangerous drug, defective medical products and medical malpractice cases. The firm also focuses on personal injury cases, including auto accidents, slip and falls, dog bites, as well as social security disability cases.

For a free consultation, call 1-800-992-6878 or visit their website for more information on Byetta.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul d'Oliveira
Visit website